In CRC patients, high levels of tumour-infiltrating TNFR2+CCR8+ Tregs, but not total Tregs, were associated with an adverse prognosis (Figure 8B), indicating that TNFR2+CCR8+ Tregs might play important roles in the progression of CRC. The gene discussed is CCR8; the disease is colorectal carcinoma.